Association of mitochondrial DNA 10398 polymorphism in invasive breast cancer in Malay population of Peninsular Malaysia

Malaysian Journal of Medical Sciences

Volumn 19, Issue 1, 2012, Pages 36-42

  Nadiah, Tengku Baharudin ^a   Hasnan, Jaafar ^b   Zafarina, Zainuddin ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Breast cancer; DNA sequencing; Genetic marker; Mitochondrial DNA; Oncology; Single nucleotide polymorphism

Indexed keywords

MITOCHONDRIAL DNA; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE BREAST CANCER; MAJOR CLINICAL STUDY; MALAYSIA; PROTEIN EXPRESSION;

EID: 84856032435     PISSN: 1394195X     EISSN: 21804303     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(Pt 2):335-344.
2. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J. 1973;134(3):707-716.
3. Higuchi M, Honda T, Proske RJ, Yeh ETH. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene. 1998;17(21):2753-2760.
4. Reed JC. Dysregulati on of apoptosis in cancer. J Clin Oncol. 1999;17(9):2941-2953.
5. Reed JC. Balancing cell life and death: Bax, apoptosis and breast Cancer. J Clin Invest. 1996;97(11): 2403-2404.
6. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267(5203): 1456-1462.
7. Yu M, Shi Y, Zhang F, Zhou Y, Yang Y, Wei X, et al. Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J Biomed Sci. 2008;15(4):535-543.
8. Zhang L, Zhang, Z, Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clinica Chimica Acta. 2005;359(1-2): 150-155.
9. Anderson S, Bankier AT, Barrell BG, de Bruijin MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290(5806):457-465.
10. MITOMAP: mtDNA coding region sequence polymorphisms [Internet]. [cited 2009 Mar 07]. Available from: http://www.mitomap.org/MITOMAP/PolymorphismsCoding.
11. Kazuno AA, Munakata K, Nagai T, Shimozono S, Tanaka M, Yoneda M, et al. Identifcation of mitochondrial dna polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet. 2006;2(8):1167-1177.
12. Kazuno AA, Munakata K, Kato N, Kato T. Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids. Int J Neuropsychopharmacol. 2008;11(1):71-78.
13. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem. 1992;267(13):8834-8839.
14. Kosel S, Grasbon-Frodl EM, Mautsh U, Egensperger R, von Eitzen U, Frishman D, et al. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics. 1998;1(3): 197-204.
15. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics. 1993;17(1):171-184.
16. Kato C, Kunugi H, Nanko S, Kato N. Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord. 2001;62(3):151-164.
17. Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 2005;65(17):8028-8033.
18. Mims MP, Hayes TG, Zheng S, Leal SM, Frolov A, Ittmann MM, et al. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American Women. Cancer Res. 2006;66(3): 1880-1881.
19. Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 2007;249(2): 249-255.
20. Czarneka AM, Krawczyk T, Zdrozny M, Lubinski J, Arnold RS, Kukwa W, et al. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat. 2009;121(2):511-518.
21. Covarrubias D, Bai RK, Wong LJC, Leal SM. Mitochondrial DNA variant interactions modify breast cancer risk. J Human Genetics. 2008;53(10): 924-928.
22. Zafarina Z. The analysis of human mitochondrial DNA in Peninsular Malaysia [PhD thesis]. Glasgow (GB): University of Glasgow; 2004.
23. Kato C, Umekage T, Tochigi M, Otowa T, Hibino H, Ohtani T, et al. Mitochondrial DNA polymorphisms and extraversion. Am J Med Genet B Neuropsychiatr Genet. 2004;128B(1):76-79.
24. Van Diest PJ, van Dam P, Henzen-Logmans SC, Berns E, van der Burg ME, Green J, et al. A scoring system for immunohistochemical staining: Consensus report of the task force for basic research of the EORTC-GCCG. J Clin Path. 1997;50(10):801-804.
25. Suzuki K, Kazui T, Yoshida M, Uno T, Kobayashi T, Kimura T, et al. Drug-induced apoptosis and p53, BCL-2 and BAX expression in breast cancer tissues in vivo and in fbroblast cells in vitro. Jpn J Clin Oncol. 1999;29(7):323-331.
26. Krajewski S, Thor AD, Edgerton SM, Moore DH 2nd, Krajewska M, Reed JC. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers. Clin Cancer Res. 1997;3(2):199-208.
27. Umemura S, Kurosumi M, Moriya T, Oyama T, Arihiro K, Yamashita H, et al. Immunohistochemical evaluation for hormone receptors in breast cancer: A practically useful evaluation system and handling protocol. Breast Cancer. 2006;13(3):232-235.
28. Esserman LJ, Shieh Y, Park JW, Ozanne EM. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007;7(5):533-544.
29. Levenson VV. Biomarkers for early detection of breast cancer: What, when and where? Biochim Biophys Acta. 2007;1770(6):847-856.
30. Tseng LM, Yin PH, Chi CW, Hsu CY, Wu CW, Lee LM, et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer. 2006;45(7):629-638.
31. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, et al. Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Breast Cancer Res. 2004;6(6):R647-655.
32. Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variants is not associated with breast cancer in African-American women. Cancer Genet Cytogenet. 2008;181(1):16-19.
33. Beckmann MW, Bani MR, Fasching PA, Strick R, Lux MP. Risk and risk assessment for breast cancer: Molecular and clinical aspects. Maturitas. 2007;57(1):56-60.
34. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. Mitochondrial genetic background modifes breast cancer risk. Cancer Res. 2007;67(10):4687-4694.
35. Ibi T, Sahashi K, Jing L, Zhang G, Mitsuma T. Immunostaining of anti-Bcl-2 antibody in diseased human muscles. Rinsho Shinkeigaku. 1996;36(6):735-740.
36. Robinson BH. Human complex I defciency: Clinical spectrum and involvement of oxygen free radicals in the pathogenecity of the defect. Biochim Biophys Acta. 1998;1364(2):271-286.
37. Binder C, Marx D, Binder L, Schauer A, Hiddemann W. Expression of Bax in relation to Bcl-2 and other predictive parameters in breast cancer. Ann Oncol. 1996;7(2):129-133.
38. Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagenert K, Kallinich B, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-α expression in tumor cells correlate with resistance towards apoptosis. Int J Cancer. 1995;60(6):854-859.
39. Dong M, Zhou JP, Zhang H, Guo KJ, Tian YL, Dong YT. Clinicopathological signifcance of Bcl-2 and Bax protein expression in human pancreatic cancer. World J Gastroenterol. 2005;11(18):2744-2747.
40. Rolland P, Spendlove I, Madjid Z, Rakha EA, Patel P, Ellis IO, et al. The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer. Int J Cancer. 2007;120(6):1311-1317.
41. Tang HL, Yuen KL, Tang HM, Fung MC. Reversibility of apoptosis in cancer cells. Br J Cancer. 2009;100(1):118-122.